SureTrader
Home > Boards > US OTC > Medical - Drugs >

Ocata Therapeutics Inc. (OCAT)

OCAT RSS Feed
Add OCAT Price Alert      Hide Sticky   Hide Intro
Moderator: elysse1kittycat, lasers, AyeEye
Search This Board:
Last Post: 2/11/2016 7:10:50 PM - Followers: 643 - Board type: Free - Posts Today: 29


 Ocata Therapeutics (OCAT)

formerly Advanced Cell Technology (ACTC):
Advanced Cell Technology Changes Name to Ocata Therapeutics

https://www.ocata.com/
 

Ocata Therapeutics Headquarters
33 Locke Drive
Marlborough, MA 01752
Tel: (508) 756-1212
Fax: (508) 229-2333
info@ocata.com 
 

Company Overview

Ocata Therapeutics, Inc. (“Ocata”; NASDAQ: OCAT), formerly named Advanced Cell Technology, is a clinical stage biotechnology company focused on the development and commercialization of new therapies in the field of regenerative medicine. Regenerative medicine is defined as the process of replacing or regenerating human cells, tissues or organs to restore or establish normal function and has been called the “next evolution of medical treatments” and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.

The company’s principal R&D and commercial efforts relate to its Regenerative Ophthalmology™ programs and involve development of therapies for the treatment of eye diseases and disorders. Beyond the eye, our other research areas include projects focusing on developing many different cell therapies that may be used to treat a range of diseases across several therapeutic categories. Ocata’s principal laboratory, GMP facility and corporate offices are in Marlborough, Massachusetts. 
 

Regenerative Ophthalmology Platform

The mission behind our Regenerative Ophthalmology efforts is clear. It is our goal to bring innovative new therapies to the market to treat diseases of the eye that otherwise may cause significant loss of vision in patients. Our emerging cell therapies focus on structural repair and functional restoration and have the potential to make a significant difference in the lives of people with ocular disorders.

We are at the forefront of developing new therapies to address some of the most significant unmet medical needs in eye diseases. These include potential treatments for diseases affecting the retina, such as age-related macular degeneration – as well as other forms of macular degeneration, diabetic retinopathy and retinitis pigmentosa, as well as inflammatory diseases such as uveitis, and vision loss from photoreceptor and other neurosensory retinal damage due to glaucoma.

  • Our lead clinical program involves RPE Cell Therapy for treating macular degeneration. Critical to the development and the rate of progression of macular degeneration is the health status of the retinal pigment epithelium, or RPE, a single layer of cells whose presence and integrity in the retina are required for normal vision. The company is currently conducting clinical trials in the U.S. andU.K. for treating Stargardt’s macular degeneration with the RPE Cell Therapy, and in the U.S. for treating patients with dry age-related macular degeneration.
    We are developing a Photoreceptor Progenitor Cell Therapy which we intend to be used for treating a wide variety of retinal degenerations in diseases where photoreceptors malfunction and/or die.
    Our Ganglion Progenitor Cell Therapy is a preclinical candidate program. In animal models of glaucoma, the injection of these cells protects against damage of existing nerve cells as well as forms new ganglion nerve cells.
    The company is also developing therapeutic platforms using Corneal Endothelial Cells for use in treating corneal blindness.

See our Pipeline of Ophthalmology Therapies »


Other Regenerative Medicine Programs

In addition to our regenerative ophthalmology programs we have invested in other programs where we feel that we can leverage our expertise in cellular and developmental biology to generate allogeneic therapies that have the potential to improve health care in other prevalent degenerative diseases and diseases of aging. At the core of our pipeline planning are approaches intended to address large unmet medical needs with allogeneic stem cell-derived therapeutics.

Our Mesenchymal Stem Cells

Our Mesenchymal Stem Cells (MSCs) represent an “off-the-shelf” cellular therapy ready for treatment of autoimmune and inflammatory diseases in both acute and chronic settings. MSCs regulate immune and inflammatory responses, providing therapeutic potential for treating diseases characterized by the presence of an inflammatory component, which makes them an attractive tool for the cellular treatment of autoimmunity and inflammation. We believe we have succeeded at creating a differentiated MSC product by producing the cells in culture from a pluripotent stem cell source.

Neuroprotective Biologics

We have discovered Neuroprotective Biologics that are secreted by certain of our neurosensory retina progenitor cell populations. We anticipate that the neuroprotective agent(s) that we may ultimately develop as drug candidates may be useful not only in retinal diseases and dystrophies, but may have broader applications in central nervous system and peripheral nervous system diseases and disorders, including diseases causing cognitive function impairment, movement disorders such as Parkinson’s Disease, and ischemic events such as caused by stroke.

Blood Components Programs

Through our Blood Components Programs, we have been able to generate Red Blood Cells, Platelets, Dendritic cells and other cells relevant immune response or hemostasis.

 

Pipeline of Therapeutic Programs

Ocata’s world-class research and development programs embody our efforts to bring transformative new therapies to market for patients facing some of hardest-to-treat eye diseases and disorders.

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001140098&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany
 

 

 


Press Releases

 

 

 

 



 


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

 

 

Rules of the board according to IHUB:
http://www.investorshub.com/boards/complex_terms.asp


 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
OCAT
Current Price
Volume:
Bid Ask Day's Range
Wiki
OCAT News: Statement of Changes in Beneficial Ownership (4) 04:39 PM
OCAT News: Statement of Changes in Beneficial Ownership (4) 04:37 PM
OCAT News: Statement of Changes in Beneficial Ownership (4) 04:33 PM
OCAT News: Statement of Changes in Beneficial Ownership (4) 04:31 PM
OCAT News: Statement of Changes in Beneficial Ownership (4) 04:30 PM
News News Alert: Statement of Changes in Beneficial Ownership (4) 02/11/2016 04:39:37 PM
PostSubject
#88104  Sticky Note I had to register just to make a comment. Enough-Already 08/26/15 05:35:48 PM
#76767  Sticky Note Ocata Therapeutics Receives Advanced Therapy Medicinal Product Designation lasers 11/24/14 12:12:44 PM
#92877   Please tell us how Gabelli sold for arbitrage[from north40000 02/11/16 08:20:54 PM
#92876   Hot off the press-I just received this. elysse1kittycat 02/11/16 07:10:50 PM
#92873   In all honesty imo in life there are elysse1kittycat 02/11/16 04:54:44 PM
#92871   If I spend that money for another stock Goodbuddy4863 02/11/16 04:15:18 PM
#92870   Perhaps Mario will "once again" emerge as the elysse1kittycat 02/11/16 04:13:24 PM
#92869   Quote BS LOL, "I can say "appraisals" are Captain Kirk 02/11/16 04:11:12 PM
#92868   Good luck with appraisal-imo nothing will ever come elysse1kittycat 02/11/16 04:04:49 PM
#92867   TDA has a record of how many shares north40000 02/11/16 04:02:16 PM
#92866   It has already happened to me. Goodbuddy4863 02/11/16 04:00:42 PM
#92865   Quote LOL, "Should I just leave the money Captain Kirk 02/11/16 04:00:36 PM
#92864   I can say "appraisals" are rather common in north40000 02/11/16 03:55:00 PM
#92863   TDAmeritrade has already listed my sold shares as Cash. Goodbuddy4863 02/11/16 03:53:59 PM
#92862   Can you say ambulance chasing as it applies elysse1kittycat 02/11/16 03:46:11 PM
#92861   Thanks: I like that. Goodbuddy4863 02/11/16 03:41:15 PM
#92860   I am very grateful to whoever got the elysse1kittycat 02/11/16 03:39:53 PM
#92859   Lets just say that in this instance is/was elysse1kittycat 02/11/16 03:24:13 PM
#92858   Nonsense, CK. Gabelli et al report that, AS north40000 02/11/16 03:24:06 PM
#92856   Mario SEC filing. CLASSIC, LOL !!!! Captain Kirk 02/11/16 03:08:37 PM
#92855   As I said yesterday, imo someone like Sanders elysse1kittycat 02/11/16 02:15:53 PM
#92854   The investing game is so incredibly rigged against farviewhill 02/11/16 01:33:09 PM
#92853   I agree again. elysse1kittycat 02/11/16 01:23:33 PM
#92852   Thanks, but for me the big take away farviewhill 02/11/16 01:16:04 PM
#92851   What a conspiracy if I ever saw one. smokey 02/11/16 12:24:09 PM
#92849   FYI In case anyone isn't aware of it, elysse1kittycat 02/11/16 08:31:46 AM
#92847   Thanks, thats what I thought would happen. :/ LODE MAKING ME RICH 02/10/16 05:06:40 PM
#92846   Lode, "I am one of those who did NOT Captain Kirk 02/10/16 04:22:16 PM
#92845   I am one of those who did NOT LODE MAKING ME RICH 02/10/16 03:10:35 PM
#92842   So true! elysse1kittycat 02/10/16 02:42:43 PM
#92841   This beyond disgusting, but once hopeful venture, and farviewhill 02/10/16 02:30:21 PM
#92838   Ocata swan-song !!! imelcooler 02/10/16 02:11:37 PM
#92836   Mario didn't get to be where he is elysse1kittycat 02/10/16 11:22:16 AM
#92835   Good Luck everyone. Its been a crazy ride fulleroots 02/10/16 11:06:25 AM
#92834   Quote LOL, "Mario Gabelli has made a $multi-million Captain Kirk 02/10/16 10:58:05 AM
#92833   ALPMY or ALPMF cty 02/10/16 10:30:30 AM
#92832   Same to you Kyrie! elysse1kittycat 02/10/16 10:12:03 AM
#92831   Well that's it folks. Celebration for a successful kyrie717 02/10/16 10:06:17 AM
#92830   I agree 100% about what you say about elysse1kittycat 02/10/16 09:47:26 AM
#92829   SAYONARA to OCATA as a public company- Captain Kirk 02/10/16 09:46:33 AM
#92827   My condolences to all the original ACTC shareholders... diannedawn 02/10/16 09:35:50 AM
#92826   Does anyone know when it will convert to Jmasdoc 02/10/16 09:34:14 AM
#92825   You're welcome. Captain Kirk 02/10/16 09:30:16 AM
#92824   And thanks to you for posting your thoughts elysse1kittycat 02/10/16 09:18:47 AM
#92822   DONE. 53%, IT'S OVER !! SEC FILED- Captain Kirk 02/10/16 09:09:23 AM
#92821   the tender is completed.... cty 02/10/16 09:07:51 AM
#92820   Quote, "Trading has been halted." Captain Kirk 02/10/16 09:05:51 AM
#92819   Trading Halt: Regulatory Reetala 02/10/16 09:05:15 AM
#92818   Trading has been halted. Something is coming down Reetala 02/10/16 09:01:25 AM
#92817   So 5 PM has come and gone. What interstate 02/10/16 08:29:49 AM
#92816   Latest updated news,Tuesday evening: north40000 02/10/16 12:51:40 AM
#92812   Miss the dreaming,so starting over with uwti and Gastrodamas 02/09/16 09:48:09 PM
PostSubject